BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lim B, Kim JH, Kim M, Kim SY. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer. World J Gastroenterol 2016; 22(3): 1190-1201 [PMID: 26811657 DOI: 10.3748/wjg.v22.i3.1190] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Jin XJ, Li JW, Li CH, Zhou SY, Li JJ, Feng CQ, Liu DL, Liu YQ. Systematic insight into the active constituents and mechanism of Guiqi Baizhu for the treatment of gastric cancer. Cancer Sci 2021;112:1772-84. [PMID: 33682294 DOI: 10.1111/cas.14851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sremac M, Paic F, Grubelic Ravic K, Serman L, Pavicic Dujmovic A, Brcic I, Krznaric Z, Nikuseva Martic T. Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma. Oncol Lett 2021;22:822. [PMID: 34691249 DOI: 10.3892/ol.2021.13083] [Reference Citation Analysis]
3 Cai H, Hou X, Ding Y, Fu Z, Wang L, Du Y. Prediction of gastric cancer prognosis in the next-generation sequencing era. Tradit Med Mod Med 2019;02:105-18. [DOI: 10.1142/s2575900019300029] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Kim JH, Eom HJ, Lim G, Park S, Lee J, Nam S, Kim YH, Jeong JH. Differential effects, on oncogenic pathway signalling, by derivatives of the HNF4 α inhibitor BI6015. Br J Cancer 2019;120:488-98. [PMID: 30792535 DOI: 10.1038/s41416-018-0374-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
5 Suzuki H, Yamada T, Sugaya A, Ueyama S, Yamamoto Y, Moriwaki T, Hyodo I. Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden. Int J Clin Oncol 2021;26:370-7. [PMID: 33090284 DOI: 10.1007/s10147-020-01810-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Basile D, Garattini SK, Bonotto M, Ongaro E, Casagrande M, Cattaneo M, Fanotto V, De Carlo E, Loupakis F, Urbano F, Negri FV, Pella N, Russano M, Brunetti O, Scartozzi M, Santini D, Silvestris N, Casadei Gardini A, Puzzoni M, Calvetti L, Cardarelli N, Aprile G. Immunotherapy for colorectal cancer: where are we heading? Expert Opin Biol Ther 2017;17:709-21. [PMID: 28375039 DOI: 10.1080/14712598.2017.1315405] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 12.4] [Reference Citation Analysis]
7 Meng N, Wang Y, Wang H, Zhou J, Wang S. Research on the Histological Features and Pathological Types of Gastric Adenocarcinoma With Mucinous Differentiation. Front Med 2022;9:829702. [DOI: 10.3389/fmed.2022.829702] [Reference Citation Analysis]
8 Zhou W, Li J, Lu X, Liu F, An T, Xiao X, Kuo ZC, Wu W, He Y. Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma. Front Oncol 2021;11:617289. [PMID: 33732644 DOI: 10.3389/fonc.2021.617289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang KC, Kang CH, Tsai CY, Chou NH, Tu YT, Li GC, Lam HC, Liu SI, Chang PM, Lin YH, Tsai KW. Ten-eleven translocation 1 dysfunction reduces 5-hydroxymethylcytosine expression levels in gastric cancer cells. Oncol Lett 2018;15:278-84. [PMID: 29285192 DOI: 10.3892/ol.2017.7264] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
10 Pinto MP, Córdova-Delgado M, Retamal IN, Muñoz-Medel M, Bravo ML, Durán D, Villanueva F, Sanchez C, Acevedo F, Mondaca S, Koch É, Ibañez C, Galindo H, Madrid J, Nervi B, Peña J, Torres J, Owen GI, Corvalán AH, Armisén R, Garrido M. A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability. Cancers (Basel) 2020;12:E1863. [PMID: 32664343 DOI: 10.3390/cancers12071863] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Malyshev BS, Netesova NA, Smetannikova NA, Abdurashitov MA, Akishev AG, Dubinin EV, Azanov AZ, Vihlyanov IV, Nikitin MK, Karpov AB, Degtyarev SK. GLAD-PCR Assay of R(5mC)GY Sites in the Regulatory Region of Tumor-Suppressor Genes Associated with Gastric Cancer. Acta Naturae 2020;12:124-33. [PMID: 33173602 DOI: 10.32607/actanaturae.11070] [Reference Citation Analysis]
12 Tang H, Ma X, Zhou L, Li W, Shu Y, Xu H, Li J, Wang F, Sun F, Duan Y. Distinct Performance of Methylated SEPT9 in Upper and Lower Gastrointestinal Cancers and Combined Detection with Protein Markers. Genet Test Mol Biomarkers 2022;26:239-48. [PMID: 35481971 DOI: 10.1089/gtmb.2021.0127] [Reference Citation Analysis]
13 Kuroda K, Yashiro M, Miki Y, Sera T, Yamamoto Y, Sugimoto A, Nishimura S, Kushiyama S, Togano S, Okuno T, Ohira M. Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2-overexpressing tumor. Cancer Sci 2020;111:4500-9. [PMID: 32946655 DOI: 10.1111/cas.14654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Liu X, Xu D, Huang C, Guo Y, Wang S, Zhu C, Xu J, Zhang Z, Shen Y, Zhao W, Zhao G. Regulatory T cells and M2 macrophages present diverse prognostic value in gastric cancer patients with different clinicopathologic characteristics and chemotherapy strategies. J Transl Med. 2019;17:192. [PMID: 31174544 DOI: 10.1186/s12967-019-1929-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
15 Abdi E, Latifi-Navid S, Zahri S, Yazdanbod A, Pourfarzi F. Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives. Cancer Med 2019;8:6114-26. [PMID: 31448582 DOI: 10.1002/cam4.2497] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
16 Tsai CK, Yeh TS, Wu RC, Lai YC, Chiang MH, Lu KY, Hung CY, Ho HY, Cheng ML, Lin G. Metabolomic alterations and chromosomal instability status in gastric cancer. World J Gastroenterol 2018; 24(33): 3760-3769 [PMID: 30197481 DOI: 10.3748/wjg.v24.i33.3760] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
17 Hissong E, Ramrattan G, Zhang P, Zhou XK, Young G, Klimstra DS, Shia J, Fernandes H, Yantiss RK. Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features. Am J Surg Pathol. 2018;42:453-462. [PMID: 29438172 DOI: 10.1097/pas.0000000000001018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
18 Xiang R, Fu T. Gastrointestinal adenocarcinoma analysis identifies promoter methylation-based cancer subtypes and signatures. Sci Rep 2020;10:21234. [PMID: 33277583 DOI: 10.1038/s41598-020-78228-y] [Reference Citation Analysis]
19 Lin S, Lin B, Wang X, Pan Y, Xu Q, He JS, Gong W, Xing R, He Y, Guo L, Lu Y, Wang JM, Huang J. Silencing of ATP4B of ATPase H+/K+ Transporting Beta Subunit by Intragenic Epigenetic Alteration in Human Gastric Cancer Cells. Oncol Res 2017;25:317-29. [PMID: 28281974 DOI: 10.3727/096504016X14734735156265] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
20 Lim B, Kim HJ, Heo H, Huh N, Baek SJ, Kim JH, Bae DH, Seo EH, Lee SI, Song KS, Kim SY, Kim YS, Kim M. Epigenetic silencing of miR-1271 enhances MEK1 and TEAD4 expression in gastric cancer. Cancer Med 2018. [PMID: 29862663 DOI: 10.1002/cam4.1605] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
21 Wang Y, Zhang L, Yang Y, Lu S, Chen H. Progress of Gastric Cancer Surgery in the era of Precision Medicine. Int J Biol Sci 2021;17:1041-9. [PMID: 33867827 DOI: 10.7150/ijbs.56735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ravegnini G, Fosso B, Saverio VD, Sammarini G, Zanotti F, Rossi G, Ricci M, D'Amico F, Valori G, Ioli A, Turroni S, Brigidi P, Hrelia P, Angelini S. Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis-Deepening Heterogeneity for a Personalized Therapy. Int J Mol Sci 2020;21:E9735. [PMID: 33419357 DOI: 10.3390/ijms21249735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Zhou W, Ouyang J, Li J, Liu F, An T, Cheng L, Kuo ZC, Zhang C, He Y. MRPS17 promotes invasion and metastasis through PI3K/AKT signal pathway and could be potential prognostic marker for gastric cancer. J Cancer 2021;12:4849-61. [PMID: 34234855 DOI: 10.7150/jca.55719] [Reference Citation Analysis]
24 Basile D, Gerratana L, Buonadonna A, Garattini SK, Perin T, Grassilli E, Miolo G, Cerrito MG, Belluco C, Bertola G, De Paoli A, Cannizzaro R, Lavitrano M, Puglisi F, Canzonieri V. Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer. Cancers (Basel) 2019;11:E880. [PMID: 31238520 DOI: 10.3390/cancers11060880] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
25 Chen ZD, Zhang PF, Xi HQ, Wei B, Chen L, Tang Y. Recent Advances in the Diagnosis, Staging, Treatment, and Prognosis of Advanced Gastric Cancer: A Literature Review. Front Med (Lausanne) 2021;8:744839. [PMID: 34765619 DOI: 10.3389/fmed.2021.744839] [Reference Citation Analysis]
26 Battaglin F, Naseem M, Puccini A, Lenz HJ. Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions. Cancer Cell Int. 2018;18:99. [PMID: 30008616 DOI: 10.1186/s12935-018-0594-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
27 Chen J, Xia YJ, Liu TY, Lai YH, Yu JS, Zhang TH, Ooi S, He YL. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data. BMC Cancer 2021;21:532. [PMID: 33971833 DOI: 10.1186/s12885-021-08249-x] [Reference Citation Analysis]
28 Lim B, Mun J, Kim SY. Intrinsic Molecular Processes: Impact on Mutagenesis. Trends Cancer 2017;3:357-71. [PMID: 28718413 DOI: 10.1016/j.trecan.2017.03.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
29 Cheng A, Guo X, Dai X, Wang Z. Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer. FEBS Open Bio 2021;11:1785-98. [PMID: 33837660 DOI: 10.1002/2211-5463.13160] [Reference Citation Analysis]
30 Mun J, Choi G, Lim B. A guide for bioinformaticians: 'omics-based drug discovery for precision oncology. Drug Discov Today 2020:S1359-6446(20)30335-4. [PMID: 32828947 DOI: 10.1016/j.drudis.2020.08.004] [Reference Citation Analysis]
31 Satala CB, Jung I, Stefan-van Staden RI, Kovacs Z, Molnar C, Bara T Jr, Fulop ZZ, Gurzu S. HER2 Heterogeneity in Gastric Cancer: A Comparative Study, Using Two Commercial Antibodies. J Oncol 2020;2020:8860174. [PMID: 33144857 DOI: 10.1155/2020/8860174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Garattini SK, Basile D, Cattaneo M, Fanotto V, Ongaro E, Bonotto M, Negri FV, Berenato R, Ermacora P, Cardellino GG, Giovannoni M, Pella N, Scartozzi M, Antonuzzo L, Silvestris N, Fasola G, Aprile G. Molecular classifications of gastric cancers: Novel insights and possible future applications. World J Gastrointest Oncol 2017; 9(5): 194-208 [PMID: 28567184 DOI: 10.4251/wjgo.v9.i5.194] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
33 Arakawa N, Sugai T, Habano W, Eizuka M, Sugimoto R, Akasaka R, Toya Y, Yamamoto E, Koeda K, Sasaki A, Matsumoto T, Suzuki H. Genome-wide analysis of DNA copy number alterations in early and advanced gastric cancers. Mol Carcinog 2017;56:527-37. [PMID: 27312513 DOI: 10.1002/mc.22514] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
34 Abdi E, Latifi-navid S, Latifi-navid H, Safaralizadeh R. LncRNA polymorphisms and upper gastrointestinal cancer risk. Pathology - Research and Practice 2021;218:153324. [DOI: 10.1016/j.prp.2020.153324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
35 Wang Q, Xie Q, Liu Y, Guo H, Ren Y, Li J, Zhao Q. Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population. Mol Med Rep 2020;22:828-40. [PMID: 32468041 DOI: 10.3892/mmr.2020.11183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Zhang HL, Liu CY, Ma W, Huang L, Li CJ, Li CS, Zhang ZW. Identification of differentially expressed proteins in the gastric mucosal atypical hyperplasia tissue microenvironment. Oncol Lett 2018;16:2355-65. [PMID: 30008939 DOI: 10.3892/ol.2018.8941] [Reference Citation Analysis]
37 Lazăr DC, Avram MF, Romoșan I, Cornianu M, Tăban S, Goldiș A. Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer. World J Gastroenterol 2018; 24(32): 3583-3616 [PMID: 30166856 DOI: 10.3748/wjg.v24.i32.3583] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 50] [Article Influence: 12.5] [Reference Citation Analysis]
38 Zhang L, Huang Z, Zhang H, Zhu M, Zhu W, Zhou X, Liu P. Prognostic value of candidate microRNAs in gastric cancer: A validation study. Cancer Biomark 2017;18:221-30. [PMID: 27983528 DOI: 10.3233/CBM-160091] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
39 Han X, Wang DZ, Yuan M, Bai WJ. Lemur tyrosine kinase 2 silencing inhibits the proliferation of gastric cancer cells by regulating GSK-3β phosphorylation and β-catenin nuclear translocation. Bioengineered 2021. [PMID: 34719320 DOI: 10.1080/21655979.2021.1999375] [Reference Citation Analysis]
40 Zhou X, Dong Z, Zhang C, Geng X, Li L, Jing J, Pan W, Lou H. A novel nomogram for predicting survival of patients with poorly differentiated gastric adenocarcinoma. Transl Cancer Res 2021;10:886-98. [PMID: 35116418 DOI: 10.21037/tcr-20-2794] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]